NOT FOR DISTRIBUTION
Header cover image

Market Cap

CA$92.4m

Last Updated

2021/05/16 23:05 UTC

Data Sources

Company Financials +

Executive Summary

Assure Holdings Corp., together with its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries to physicians. More Details


Snowflake Analysis

High growth potential and fair value.

Share Price & News

How has Assure Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IOM is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: IOM's weekly volatility (12%) has been stable over the past year.


Market Performance


7 Day Return

0.6%

IOM

-3.9%

CA Healthcare

-0.7%

CA Market


1 Year Return

43.6%

IOM

32.8%

CA Healthcare

39.3%

CA Market

Return vs Industry: IOM exceeded the Canadian Healthcare industry which returned 32.5% over the past year.

Return vs Market: IOM exceeded the Canadian Market which returned 39.3% over the past year.


Shareholder returns

IOMIndustryMarket
7 Day0.6%-3.9%-0.7%
30 Day1.3%-6.7%0.7%
90 Day-10.7%-8.6%6.1%
1 Year43.6%43.6%35.4%32.8%43.8%39.3%
3 Yearn/a81.8%60.0%28.5%16.3%
5 Yearn/a12.7%-14.0%58.4%34.6%

Long-Term Price Volatility Vs. Market

How volatile is Assure Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Assure Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: IOM (CA$1.58) is trading below our estimate of fair value (CA$31.19)

Significantly Below Fair Value: IOM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: IOM is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.

PE vs Market: IOM is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IOM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IOM is good value based on its PB Ratio (3.9x) compared to the CA Healthcare industry average (4.2x).


Future Growth

How is Assure Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

158.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IOM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).

Earnings vs Market: IOM is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IOM's is expected to become profitable in the next 3 years.

Revenue vs Market: IOM's revenue (91.7% per year) is forecast to grow faster than the Canadian market (6.4% per year).

High Growth Revenue: IOM's revenue (91.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IOM's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Assure Holdings performed over the past 5 years?

-66.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IOM is currently unprofitable.

Growing Profit Margin: IOM is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IOM is unprofitable, and losses have increased over the past 5 years at a rate of 66.9% per year.

Accelerating Growth: Unable to compare IOM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IOM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%).


Return on Equity

High ROE: IOM has a negative Return on Equity (-84.13%), as it is currently unprofitable.


Financial Health

How is Assure Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: IOM's short term assets ($25.8M) exceed its short term liabilities ($7.7M).

Long Term Liabilities: IOM's short term assets ($25.8M) exceed its long term liabilities ($7.6M).


Debt to Equity History and Analysis

Debt Level: IOM's debt to equity ratio (43%) is considered high.

Reducing Debt: IOM's debt to equity ratio has increased from 6.5% to 43% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if IOM has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if IOM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Assure Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IOM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IOM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IOM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IOM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IOM's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

John Farlinger (61 yo)

3yrs

Tenure

US$870,667

Compensation

Mr. John Allen Farlinger, CA, serves as a Director at Lite Access Technologies Inc. since April 2021. He has been Executive Chairman of Assure Holdings Corp. since May 15, 2018 and its Chief Executive Offi...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD870.67K) is above average for companies of similar size in the Canadian market ($USD157.14K).

Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: IOM's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: IOM's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IOM insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 68%.


Top Shareholders

Company Information

Assure Holdings Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Assure Holdings Corp.
  • Ticker: IOM
  • Exchange: TSXV
  • Founded: NaN
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$92.366m
  • Shares outstanding: 58.46m
  • Website: https://www.assureneuromonitoring.com

Number of Employees


Location

  • Assure Holdings Corp.
  • 4600 South Ulster Street
  • Suite 1225
  • Denver
  • Colorado
  • 80237
  • United States

Listings


Biography

Assure Holdings Corp., together with its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries to phy...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/16 23:05
End of Day Share Price2021/05/14 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.